Clinical Trial Update: RONICICLIB / Placebo in Combination With Chemotherapy in Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of RONICICLIB in combination with chemotherapy for small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Roniciclib (roniciclib)

Snippet

Sponsor: Bayer | Conditions: Small Cell Lung Carcinoma | Phase 2 | Status: TERMINATED